Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes.

Hartman ML, Sanyal AJ, Loomba R, Wilson JM, Nikooienejad A, Bray R, Karanikas CA, Duffin KL, Robins DA, Haupt A.
Diabetes Care. 2020 Apr 14. pii: dc191892. doi: 10.2337/dc19-1892.

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?